Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by OldRedon Jan 12, 2011 5:57am
265 Views
Post# 17958089

Sirona Biochem Corp Receives Funding From Going Gl

Sirona Biochem Corp Receives Funding From Going GlMonday, 29 Nov 2010 02:02pm EST 

Sirona Biochem Corp. announced that it has received funding from Going Global Innovation. Sirona Biochem received funding for expenses related to creating a collaboration with France-based biotechnology company TFChem. Sirona Biochem has signed a preliminary binding letter of intent to acquire TFChem. Going Global Innovation is the innovation, science and technology pillar of the Global Commerce Support Program (GCSP) for Foreign Affairs and International Trade Canada. The objectives of Going Global are to promote and enhance Canada's international innovation efforts by supporting Canadian companies and/or researchers in pursuing international research and development collaborative opportunities through the development of partnerships with key players in other countries and economies. 

Bullboard Posts